ProfileOfResearchers

TÃTULO: 18 Obesity as a post-operative risk factor for women undergoing open radical hysterectomy
AUTORES: Bethany Werner; Steven B Holloway; Kevin M Kremer; Salvatore LoCoco; David Scott Miller ; Jayanthi Lea;
PUBLICAÇÃO: 2022, FONTE: Gynecologic Oncology Reports, VOLUME: 44

INDEXADO EM:

CrossRef

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: 2022-RA-653-ESGO The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775
AUTORES: Domenica Lorusso; Vicky Makker; Antonio Casado Herraez; Bradley J Monk; Helen Mackay; Alessandro D Santin; David Scott Miller ; Richard Moore; Sally Baron-Hay; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Jie Huang; Jodi McKenzie; Gianmaria Barresi; Nicoletta Colombo;
PUBLICAÇÃO: 2022, FONTE: Endometrial cancer

INDEXADO EM:

CrossRef: 1

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: 2022-RA-722-ESGO Phase 2 study assessing the efficacy of adding AL3818 (Catequentinib Dihydrochloride, Anlotinib Hydrochloride) to chemotherapies in subjects with platinum resistant ovarian carcinoma Full Text
AUTORES: David Scott Miller ; Matthew Carlson; Jayanthi Lea; Zhe Li; May Gan; Judy Chen; Agustin Garcia; Matthew Schlumbrecht; Matt Pearson; Marilyn Huang;
PUBLICAÇÃO: 2022, FONTE: Ovarian cancer

INDEXADO EM:

CrossRef

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: 20MO Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L+P) or treatment of physician’s choice (TPC)
AUTORES: Lorusso, D; Colombo, N; Casado Herraez, A; A.D Santin; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; S.E Baron-Hay; I.L Ray-Coquard; Shapira-Frommer, R; Y.M Kim; McCormack, M; Massaad, R; Martin Nguyen, A; Zhao, Q; McKenzie, J; V.S Prabhu; Makker, V;
PUBLICAÇÃO: 2022, FONTE: Annals of Oncology, VOLUME: 33

INDEXADO EM:

CrossRef: 1

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: 45 Disparities in carcinosarcoma: public vs private hospital system
AUTORES: Larissa Aroche-Gutierrez; Donald D McIntire; Jayanthi Lea; Salvatore LoCoco; Matthew Carlson; David Scott Miller ;
PUBLICAÇÃO: 2022, FONTE: Gynecologic Oncology Reports, VOLUME: 44

INDEXADO EM:

CrossRef

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: 525MO Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775
AUTORES: Makker, V; Colombo, N; Casado Herraez, A; B.J Monk; Mackay, H; A.D Santin; David Scott Miller ; R.G Moore; S.E Baron-Hay; I.L Ray-Coquard; Shapira-Frommer, R; Ushijima, K; Yonemori, K; Y.M Kim; E.M Guerra Alia; U.A Sanli; Huang, J; McKenzie, J; Barresi, G; Lorusso, D;
PUBLICAÇÃO: 2022, FONTE: Annals of Oncology, VOLUME: 33

INDEXADO EM:

CrossRef: 2

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study Full Text
AUTORES: Brian M Slomovitz; Virginia L Filiaci; Joan L Walker; Michael C Taub; Karen A Finkelstein; John W Moroney; Aimee C Fleury; Carolyn Y Muller; Laura L Holman; Larry J Copeland; David Scott Miller ; Robert L Coleman;
PUBLICAÇÃO: 2022, FONTE: Gynecologic Oncology, VOLUME: 164, NÚMERO: 3

INDEXADO EM:

Scopus

CrossRef: 37

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: Efficacy of next line of therapy after treatment with lenvatinib (LEN) in combination with pembrolizumab (pembro) versus treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Exploratory analysis of Study 309/KEYNOTE-775.
AUTORES: Vicky Makker; Nicoletta Colombo; Alessandro Santin; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Isabelle Laure Ray-Coquard; Yong Man Kim; Eva M Guerra; Jie Huang; Gianmaria Barresi; Jodi McKenzie; Domenica Lorusso;
PUBLICAÇÃO: 2022, FONTE: Journal of Clinical Oncology, VOLUME: 40, NÚMERO: 16_suppl

INDEXADO EM:

CrossRef: 1

NO MEU:

ORCID |

CIÊNCIAVITAE

TÃTULO: Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study Full Text
AUTORES: Yovanni Casablanca; Guisong Wang; Heather A Lankes; Chunqiao Tian; Nicholas W Bateman; Caela R Miller; Nicole P Chappell; Laura J Havrilesky; Amy Hooks Wallace; Nilsa C Ramirez; David Scott Miller ; Julie Oliver; Dave Mitchell; Tracy Litzi; Brian E Blanton; William J Lowery; John I Risinger; Chad A Hamilton; Neil T Phippen; Thomas P Conrads; David Mutch; Katherine Moxley; Roger B Lee; Floor Backes; Michael J Birrer; Kathleen M Darcy; George Larry Maxwell; ...Mais
PUBLICAÇÃO: 2022, FONTE: Cancers, VOLUME: 14, NÚMERO: 17

INDEXADO EM:

Scopus

CrossRef